Chronic intermittent nicotine treatment dose-dependently alters serotonergic neurons response to citalopram in the rat

Pharmacology Biochemistry and Behavior

Volumn 89, Issue 3, 2008, Pages 338-344

  Touiki, Khalid ^a,c   Rat, Pascal ^a   Arib, Ouafa ^a,c   Molimard, Robert ^a   Chait, Abderrahman ^b   de Beaurepaire, Renaud ^a,c  

^a Centre Hospitalier Paul Guiraud   (France)

^b FACULTÉ DES SCIENCES SEMLALIA   (Morocco)

^c INSERM   (France)

Author keywords

Antidepressant; Citalopram; Firing; Sensitivity; Tobacco

Indexed keywords

CITALOPRAM; NICOTINE TARTRATE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; LOW DRUG DOSE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL;

NICOTIANA TABACUM; RATTUS; RODENTIA;

EID: 40849094163     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.01.005     Document Type: Article

References (32)

1. Aghajanian G.K., Haigler H.J., and Bloom F.E. Lysergic acid diethylamide and serotonin: direct actions on serotonin containing neurons in rat brain. Life Sci 11 (1972) 615-622
2. Besson M., Granon S., Mameli-Engvall M., Cloëz-Tayarani I., Maubourguet N., Cormier A., et al. Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc Natl Acad Sci (USA) 104 (2007) 8155-8160
3. Cheeta S., Irvine E.E., Kenny P.J., and File S.E. The dorsal raphe nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses. Psychopharmacology 155 (2001) 78-85
4. Corrigall W.A., Coen K.M., and Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653 (1994) 278-284
5. Crooks P.A., Li M., and Dwoskin L.P. Metabolites of nicotine in rat brain after peripheral nicotine administration. Cotinine, nornicotine, and norcotinine. Drug Metab Dispos 25 (1997) 47-54
6. Egger G., Sadjak A., Porta S., Supanz S., and Pürstner P. Laboratory handling and its influence on hormonal and metabolic parameters during acute inflammation in rats-a critique of long-term treatment by repeated injections. Horm Metab Res 18 (1986) 746-749
7. Engberg G., Erhardt S., Sharp T., and Hajos M. Nicotine inhibits firing activity of dorsal raphe 5-HT neurons in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 362 (2000) 41-45
8. 1A receptor antagonist. Behav Brain Res 73 (1996) 337-353
9. Fornal C.A., Metzler C.W., Gallegos R.A., Veasey S.C., McCreary A.C., and Jacobs B.L. WAY-100635, a potent and selective 5-hydroxytryptamine 1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100635. J Pharmacol Exp Ther 278 (1996) 752-762
10. 14C]nicotine. Drug Metab Dispos 27 (1999) 1448-1455
11. 14C]nicotine. Drug Metab Dispos 29 (2001) 645-651
12. Harrison A.A., Liem Y.T., and Markou A. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology 25 (2001) 55-71
13. Hughes J.R., and Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43 (1986) 289-294
14. Hyttel J. Citalopram: pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatry 6 (1982) 277-295
15. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther 268 (1994) 1432-1443
16. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol 352 (1995) 141-148
17. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44 (1998) 151-162
18. Malone K.M., Waternaux C., Haas G.L., Cooper T.B., Li S., and Mann J.J. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry 160 (2003) 773-779
19. Maudhuit C., Jolas T., Chastanet M., Hamon M., and Adrien J. Reduced inhibitory potency of serotonin reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep. Biol Psychiatry 40 (1996) 1000-1007
20. Maudhuit C., Prévot E., Dangoumau L., Martin P., Hamon M., and Adrien J. Antidepressant treatment in helpless rats: effect on the electrophysiological activity of raphe dorsalis serotonergic neurons. Psychopharmacology 130 (1997) 269-275
21. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, Sydney
22. Pich E.M., Pagliusi S.R., Tessari M., Talabot-Ayer D., Hooft van Huijsduijnen R., and Chiamulera C. Common neural substrates for the addictive properties of nicotine and cocaine. Science 275 (1997) 83-86
23. 1A agonist 8-OH-DPAT. Psychopharmacology 33 (1997) 343-346
24. Ribeiro E.B., Bettiker R.I., Bodganov M., and Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res 621 (1993) 311-318
25. Salín-Pascual R.J., de la Fuente J.R., Galicia-Polo L., and Drucker-Colín R. Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 121 (1995) 476-479
26. Semba J., Mataki C., Yamada S., Nankai M., and Toru M. Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats. Biol Psychiatry 43 (1998) 389-391
27. Seth P., Cheeta S., Tucci S., and File S.E. Nicotine-serotonergic interactions in brain and behaviour. Pharmacol Biochem Behav 71 (2002) 795-805
28. Touiki K., Rat P., Molimard R., Chait A., and de Beaurepaire R. Harmane inhibits dorsal raphe neurons in the rat. Psychopharmacology 182 (2005) 562-569
29. Touiki K., Rat P., Molimard R., Chait A., and de Beaurepaire R. Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat. NeuroReport 18 (2007) 925-929
30. Ulrich Y.M., Hargreaves K.M., and Flores C.M. A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites. Neuropharmacology 36 (1997) 1119-1125
31. Xu Z., Seilder F.J., Ali S.F., Slikker Jr. W., and Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res 914 (2001) 166-178
32. Zevin S., and Benowitz N.L. Pharmacokinetics and pharmacodynamics of nicotine. In: Piasecki M., and Newhouse M. (Eds). Nicotine in psychiatry (2000), American Psychiatric Press, Washington 37-57